LISATA THERAPEUTICS, INC. - COM (LSTA)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COM
Total 13F shares
785,678
Share change
+19,014
Total reported value
$2,334,671
Price per share
$2.98
Number of holders
19
Value change
+$56,439
Number of buys
5
Number of sells
3

Institutional Holders of LISATA THERAPEUTICS, INC. - COM (LSTA) as of Q4 2024

As of 31 Dec 2024, LISATA THERAPEUTICS, INC. - COM (LSTA) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 785,678 shares. The largest 10 holders included BML Capital Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, STATE STREET CORP, Cook Wealth, LLC, and BANK OF AMERICA CORP /DE/. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.